-->
Reliance seeks nod to buy Johnson & Johnson’s jabs: Reliance Foundation will import and receive the shipment from the USA to administer entire workforce pan India

Reliance seeks nod to buy Johnson & Johnson’s jabs: Reliance Foundation will import and receive the shipment from the USA to administer entire workforce pan India

The philanthropic arm of Mukesh Ambani’s RIL aims to captive consumption and to inoculate its workforce pan-India

The Foundation may source additional quantities too, the company is learnt to have said
PTI   |   New Delhi   |   05.06.21 :   The Reliance Foundation, the philanthropic arm of Mukesh Ambani’s Reliance Industries, has sought the government’s authorisation to import 20 lakh doses of US-based Johnson & Johnson’s Covid-19 vaccine for captive consumption and to inoculate its workforce pan-India, sources said.

“Reliance Foundation will import and receive the shipment of Johnson & Johnson’s Janssen Covid-19 vaccine from the USA with the purpose of captive consumption and to administer our entire workforce pan India. Import of this vaccine shall be administered within the organisation only and not at all for commercial purpose,” a source quoted the Reliance Foundation as having communicated to the health ministry.

The Foundation may source additional quantities too, the company is learnt to have said. It may also explore the possibility of importing jabs from other vaccine producers for internal use only, the organisation has said. 

Related Posts

0 Response to "Reliance seeks nod to buy Johnson & Johnson’s jabs: Reliance Foundation will import and receive the shipment from the USA to administer entire workforce pan India"

Post a Comment

Disclaimer Note:
The views expressed in the articles published here are solely those of the author and do not necessarily reflect the official policy, position, or perspective of Kalimpong News or KalimNews. Kalimpong News and KalimNews disclaim all liability for the published or posted articles, news, and information and assume no responsibility for the accuracy or validity of the content.
Kalimpong News is a non-profit online news platform managed by KalimNews and operated under the Kalimpong Press Club.

Comment Policy:
We encourage respectful and constructive discussions. Please ensure decency while commenting and register with your email ID to participate.

Note: only a member of this blog may post a comment.